共 17 条
[1]
Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. Burkhardt MS,Foster JK,Laws SM. Journal of Alzheimer s Disease . 2004
[2]
Neurology[C]. The 5th International Congress of Pathophysiology,2006
[3]
Lipid metabolism in cognitive decline and dementia. Panza F,D’Introno A,Colacicco AM,et al. Brain Research . 2006
[4]
Variation at the APOE 491 promoter locus is associated with altered brain levels of apolipoprotein E. Laws SM,Hone E,Taddei K,et al. Molecular Psychiatry . 2002
[5]
Neurological soft signs are associated with APOE genotype, age and cognitive performance. Lautenschlager NT,Wu JS,Laws SM,et al. Journal of Alzheimer s Disease . 2005
[6]
The 491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer’s disease. Laws SM,Taddei K,Martins G,et al. NeuroReport . 1999
[7]
Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer’s disease. Reiss AB,Siller KA,Rahman MM,et al. Neurobiology of Aging . 2004
[8]
Association study of Notch 4 polymorphisms with Alzheimer’s disease. Lambert JC,Mann D,Harris J,et al. Journal of Neurology Neurosurgery and Psychiatry . 2004
[9]
The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer’s disease. Lambert JC,Coyle N,Lendon C. Journal of Medical Genetics . 2004
[10]
Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. Kolsch H,Heun R,Kerksiek A,et al. Neuroscience Letters . 2004